Immune Thrombocytopenia following COVID-19 Vaccine
Copyright © 2022 Sonal Prasad et al..
Several vaccines have been developed and are being administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common side effects include fever, chills, headache, myalgia, and soreness at the injection site. However, some rare adverse effects have also been reported. We present a case of induced thrombocytopenia presenting with petechiae and mucosal bleeding which developed as an adverse response after first-dose administration of the Moderna COVID-19 vaccine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2022 |
|---|---|
| Enthalten in: |
Case reports in hematology - 2022(2022) vom: 13., Seite 6013321 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Prasad, Sonal [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 16.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1155/2022/6013321 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343161583 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343161583 | ||
| 003 | DE-627 | ||
| 005 | 20231226015801.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1155/2022/6013321 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1143.xml |
| 035 | |a (DE-627)NLM343161583 | ||
| 035 | |a (NLM)35795543 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Prasad, Sonal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immune Thrombocytopenia following COVID-19 Vaccine |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2022 Sonal Prasad et al. | ||
| 520 | |a Several vaccines have been developed and are being administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Common side effects include fever, chills, headache, myalgia, and soreness at the injection site. However, some rare adverse effects have also been reported. We present a case of induced thrombocytopenia presenting with petechiae and mucosal bleeding which developed as an adverse response after first-dose administration of the Moderna COVID-19 vaccine | ||
| 650 | 4 | |a Case Reports | |
| 700 | 1 | |a Jariwal, Roopam |e verfasserin |4 aut | |
| 700 | 1 | |a Adebayo, Moujidin |e verfasserin |4 aut | |
| 700 | 1 | |a Jaka, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Petersen, Greti |e verfasserin |4 aut | |
| 700 | 1 | |a Cobos, Everardo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Case reports in hematology |d 2011 |g 2022(2022) vom: 13., Seite 6013321 |w (DE-627)NLM220557616 |x 2090-6560 |7 nnns |
| 773 | 1 | 8 | |g volume:2022 |g year:2022 |g day:13 |g pages:6013321 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1155/2022/6013321 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2022 |j 2022 |b 13 |h 6013321 | ||